Literature DB >> 3711289

Critical evaluation of amdinocillin disk susceptibility tests correlated with agar dilution tests.

A L Barry.   

Abstract

Tests with 10-micrograms amdinocillin disks were performed in parallel with agar dilution tests and three different ranges of inoculum density. A resistance breakpoint of less than or equal to 13 mm and an intermediate category of 14 to 16 mm are recommended. Susceptible strains provided zones greater than or equal to 17 mm in diameter, but many appeared to be resistant by the agar dilution methods if the inoculum exceeded 10(4) CFU per spot.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3711289      PMCID： PMC268770          DOI： 10.1128/jcm.23.5.983-985.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  10 in total

1.  Antibacterial activity of mecillinam.

Authors:  D S Reeves
Journal:  J Antimicrob Chemother       Date:  1977-07       Impact factor: 5.790

2.  Mecillinam--an amidino penicillin which acts synergistically with other beta-lactam compounds.

Authors:  H C Neu
Journal:  J Antimicrob Chemother       Date:  1977-07       Impact factor: 5.790

3.  A laboratory evaluation of a novel (beta-lactam antibiotic mecillinam.

Authors:  D S Reeves; R Wise; M J Bywater
Journal:  J Antimicrob Chemother       Date:  1975-09       Impact factor: 5.790

4.  Mecillinam, a novel penicillanic acid derivative with unusual activity against gram-negative bacteria.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

5.  Appraisal of disk sensitivity tests with mecillinam.

Authors:  J D Anderson; M Y Aird; F Eftekhar; B J Morrison
Journal:  Chemotherapy       Date:  1981       Impact factor: 2.544

6.  Influence of inoculum growth phase on microdilution susceptibility tests.

Authors:  A L Barry; R E Badal; R W Hawkinson
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

7.  Parenteral amdinocillin for treatment of complicated urinary tract infections.

Authors:  C E Cox
Journal:  Am J Med       Date:  1983-08-29       Impact factor: 4.965

Review 8.  Review of clinical experience with amdinocillin monotherapy and comparative studies.

Authors:  C H Demos; E Green
Journal:  Am J Med       Date:  1983-08-29       Impact factor: 4.965

9.  Enhanced activity of beta-lactam antibiotics with amdinocillin in vitro and and in vivo.

Authors:  R Cleeland; E Squires
Journal:  Am J Med       Date:  1983-08-29       Impact factor: 4.965

Review 10.  Correlation of the results of antibiotic synergy and susceptibility testing in vitro with results in experimental mouse infections.

Authors:  H D Isenberg; J Sampson-Scherer; R Cleeland; E Titsworth; G Beskid; J G Christenson; W F DeLorenzo; J Unowsky
Journal:  Crit Rev Microbiol       Date:  1982       Impact factor: 7.624
  10 in total
  1 in total

1.  Collaborative clinical laboratory study of a broth-disk test for determination of bacterial susceptibility to beta-lactams in combination with amdinocillin.

Authors:  H D Isenberg; R C Tilton; A L Barry; G Beskid; R Cleeland; V Fallat; P R Murray; C Pierson; E Squires
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.